Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CytomX Therapeutics Inc (CTMX)
NASDAQ:CTMX
Holding CTMX?
Track your performance easily
See the Price Targets and Ratings of:
CTMX Analyst Ratings
Moderate Buy
2 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CTMX Stock 12 Month Forecast
Average Price Target
$3.38
▲(286.90% Upside)
| Highest Price Target$3.50 | Average Price Target$3.38 | Lowest Price Target$3.25 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
Reiterated
11/11/24
Piper Sandler
Reiterated
11/08/24
Barclays
Reiterated
11/08/24
BMO Capital
$3.59→$3.56
Hold
307.51%
Upside
Reiterated
08/09/24
CytomX Therapeutics (CTMX) PT Lowered to $3.56 at BMO CapitalBMO Capital analyst Etzer Darout lowered the price target on CytomX Therapeutics (NASDAQ: CTMX) to $3.56 (from $3.59) while maintaining a Market Perform rating.
Wedbush
$8
Buy
815.75%
Upside
Reiterated
08/09/24
CytomX Therapeutics (CTMX) Gets a Buy from Wedbush
Jefferies
$2.5→$8
Buy
815.75%
Upside
Upgraded
05/05/24
Buy Rating for CytomX Therapeutics on Promising CX-904 Probody Therapy Prospects
J.P. Morgan
―
Hold
―
Upgraded
04/22/24
Analysts Offer Insights on Healthcare Companies: Cyclo Therapeutics (NASDAQ: CYTH), CytomX Therapeutics (NASDAQ: CTMX) and Pacific Biosciences (NASDAQ: PACB)
Mizuho Securities
$2
Hold
128.94%
Upside
Reiterated
01/05/24
Cautious Hold on CytomX Amid Awaiting Clinical Validation and Financial Outlook
Best Analysts Covering CytomX Therapeutics
Which Analyst Should I Follow If I Want to Buy CTMX and Sell After:
1 Month
xxx
Success Rate
6/10 ratings generated profit
Average Return
+1.32%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +1.32% per trade.
3 Months
xxx
Success Rate
4/10 ratings generated profit
Average Return
-3.89%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -3.89% per trade.
1 Year
Success Rate
4/10 ratings generated profit
Average Return
-16.04%
reiterated a buy rating 3 months ago
Copying Robert Driscoll's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -16.04% per trade.
2 Years
xxx
Success Rate
2/10 ratings generated profit
Average Return
-35.06%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 20.00% of your transactions generating a profit, with an average return of -35.06% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CTMX Analyst Recommendation Trends
Rating
May 24
Jun 24
Aug 24
Sep 24
Nov 24
Strong Buy
3
3
5
2
4
Buy
2
1
1
0
0
Hold
8
5
6
4
4
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
9
12
6
8
Each month's total comprises the sum of three months' worth of ratings.
CTMX Financial Forecast
CTMX Stock Forecast FAQ
What is CTMX’s average 12-month price target, according to analysts?
Based on analyst ratings, CytomX Therapeutics Inc’s 12-month average price target is $3.38.
What is CTMX’s upside potential, based on the analysts’ average price target?
CytomX Therapeutics Inc has 286.90% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CTMX a Buy, Sell or Hold?
CytomX Therapeutics Inc has a consensus rating of Moderate Buy which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
What is CytomX Therapeutics Inc’s price target?
The average price target for CytomX Therapeutics Inc is $3.38. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $3.50 ,the lowest forecast is $3.25. The average price target represents 286.90% Increase from the current price of $0.874.
The highest analyst price target is $3.50 ,the lowest forecast is $3.25. The average price target represents 286.90% Increase from the current price of $0.874.
What do analysts say about CytomX Therapeutics Inc?
CytomX Therapeutics Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of CTMX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.